The predicted causal effect for each of the L.HDLs on clinical AD using non-ApoE–related IVs were in the negative direction with a similar magnitude of effect across point estimates (OR range: 0.89 to 0.91). The gene discussed is APOE; the disease is Alzheimer disease.